Cluster Analysis of Biochemical Markers as Predictor of COVID-19 Severity
DOI:
https://doi.org/10.21123/bsj.2022.7454Keywords:
COVID-19, Cluster Analysis, C- reactive protein CRP, D-dimer, Ferritin, Lactate dehydrogenase LDHAbstract
Numerous blood biomarkers are altered in COVID-19 patients; however, no early biochemical markers are currently being used in clinical practice to predict COVID-19 severity. COVID-19, the most recent pandemic, is caused by the SRS-CoV-2 coronavirus. The study was aimed to identify patient groups with a high and low risk of developing COVID-19 using a cluster analysis of several biomarkers. 137 women with confirmed SARS CoV-2 RNA testing were collected and analyzed for biochemical profiles. Two-dimensional automated hierarchy clustering of all biomarkers was applied, and patients were sorted into classes. Biochemistry marker variations (Ferritin, lactate dehydrogenase LDH, D-dimer, and C- reactive protein CRP) have split COVID-19 patients into two groups(severe cases and non-severe cases groups). Ferritin, lactate dehydrogenase LDH, D-dimer and CRP were markedly increased in COVID-19 patients in the first group (severe cases). Our findings imply that early measured levels of (Ferritin, lactate dehydrogenase LDH, D-dimer, and C- reactive protein CRP) are linked to a decreased probability of COVID-19 severity. Elevated levels of this biomarker may predict COVID severity development.
Received 25/5/2022
Accepted 3/8/2022
Published Online First 25/11/2022
References
Kim HK, Ahn J, Atkinson L, Kahlor LA. Effects of COVID-19 misinformation on information seeking, avoidance, and processing: A multicountry comparative study. Sci Commun. 2020 Oct; 42(5): 586-615.
Yunus AA, Yunus AA, Ibrahim MS, Ismail S. Future of Mathematical Modelling: A Review of COVID-19 Infected Cases Using SIR Model. Baghdad Sci J. 2021: 18(1): 824-9.
Malik SUF, Chowdhury PA, Hakim A, Islam MS, Alam MJ, Azad AK. Blood biochemical parameters for assessment of COVID-19 in diabetic and non-diabetic subjects: a cross-sectional study. Int J Environ Health Res. 2022 Jun; 32(6): 1344-1358. doi: 10.1080/09603123.2021.1879741. Epub 2021 Jan 27. PMID: 33504213.
Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res. 2020 Dec; 21(1): 1-4.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507–513.
Pranata R, Huang I, Lukito AA, Raharjo SB. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgrad Med J. 2020 Jul 1; 96(1137): 387-91.
Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care 2020; 8(36): 1-10
Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020 Jun; 14: 1753466620937175.
Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. 2020; 46(5): 837-40.
Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020 Jul 1; 146(1): 128-36.
Feketea GM, Vlacha V. The Diagnostic Significance of Usual Biochemical Parameters in Coronavirus Disease 19 (COVID-19): Albumin to Globulin Ratio and CRP to Albumin Ratio. Front Med (Lausanne) 2020; 7: 566591
Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med. 2020 Jun 1; 201(11): 1380-8.
Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1; 180(7): 934-43.
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr 1; 20(4): 425-34.
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020 Jun 1; 127: 104370.
Khaleel FM, Muhi SA, Selman AD. Assessment of Pro Hepcidin and Related with Iron Profile on Hemodialysis Men Patients. Baghdad Sci J. 2016; 13(1): 74-81
Connelly K G, Moss M, Parsons P E, Moore E E, Moore F A, Giclas P C. Serum ferritin as a predictor of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997; 155: 21–25
Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients. J infection. 2020 Oct 1; 81(4): 647-79.
. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med.. 2020 Apr 30; 382(18): 1708-20.
. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. 2020 May 1; 5(5): 428-30.
Shi J, Li Y, Zhou X, Zhang Q, Ye X, Wu Z, et al Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study. BMC Med. 2020 Dec; 18(1): 1-6.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798): 270 –3.
Ahmed TH, Al-Mousawi NH. Post-hospitalization, levels of D-dimer, C-reactive protein, ferritin, and lactate dehydrogenase in recovered COVID-19 Iraqi patients. Sys Rev Pharm. 2020; 12(1): 92-9.
Han Y, Zhang H, Mu S, Wei W, Jin C, Tong C, et al . Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study. Aging (Albany NY). 2020 Jun 6; 12(12): 11245.
Olson JD. D-dimer: an overview of hemostasis and fibrinolysis, assays, clinical applications. Adv Clin Chem. 2015; 69: 1–46. doi: 10.1016/bs.acc.2014.12.001
Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: A pooled analysis. Thromb Haemost. (2020) 120:876– 8. doi: 10.1055/s-0040-1709650
Emin M. D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis. Tuberk Toraks. 2020; 68(4): 353-60.
Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, Ebrahimpour S, Babazadeh A, Mehraeen R, et al.C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients. Interdiscip Perspect Infect Dis. 2021 Apr 23;2021.
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020 Jun 1; 127: 104370.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Baghdad Science Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
